Related Experiment Video
Updated: Feb 11, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Serum-Derived Extracellular Vesicles Protect Against Acute Myocardial Infarction by Regulating miR-21/PDCD4 Signaling
Huanyu Gu1, Zhuyuan Liu1, Yongqin Li2
1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract:
Acute myocardial infarction (AMI) represents a leading cause of morbidity and mortality worldwide. Extracellular vesicles (EVs) are being recognized as a promising therapeutic approach in protecting against MI. Serum is a rich source of EVs, which transports various microRNAs (miRNAs, miRs). EVs from serum have been shown beneficial for protecting against ischemia-reperfusion injury; however, their roles in AMI are unclear. In addition, whether a miRNA might be responsible for the effects of serum EVs on protecting against AMI is undetermined. Here, we demonstrated that serum EVs significantly reduced cardiomyocytes apoptosis in both cellular and mouse models of AMI, and dramatically attenuated the infarct size in mouse hearts after AMI. Inhibition of miR-21 was shown to reduce the protective effects of serum EVs in inhibiting cardiomyocytes apoptosis. miR-21 was decreased in mouse hearts after AMI, while serum EVs increased that. In addition, the programmed cell death 4 (PDCD4) expression was identified as a target gene of miR-21. Therefore, our study showed the protective effects of serum EVs on AMI, and provided a novel strategy for AMI therapy.
Insights
Serum extracellular vesicles (EVs) protect against acute myocardial infarction (AMI) by reducing heart cell death. A specific microRNA, miR-21, within these EVs is key to this protective effect, offering a new therapeutic avenue for AMI.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Biomedical Engineering
Background:
- Acute myocardial infarction (AMI) is a major global health concern.
- Extracellular vesicles (EVs) in serum show potential for treating myocardial infarction (MI).
- The specific role of serum EVs and their microRNAs in AMI remains largely unknown.
Purpose of the Study:
- To investigate the protective effects of serum EVs against AMI.
- To determine if specific microRNAs mediate the cardioprotective actions of serum EVs in AMI.
- To identify the molecular mechanisms underlying serum EV-mediated protection in AMI.
Main Methods:
- Utilized cellular and mouse models of AMI.
- Administered serum EVs and assessed their impact on cardiomyocyte apoptosis and infarct size.
- Investigated the role of miR-21 by inhibiting its function and analyzing its target gene, PDCD4.
Main Results:
- Serum EVs significantly reduced cardiomyocyte apoptosis and infarct size in AMI models.
- Inhibition of miR-21 diminished the protective effects of serum EVs.
- Serum EVs increased miR-21 levels in the heart post-AMI, targeting PDCD4 expression.
Conclusions:
- Serum EVs exert significant protective effects against acute myocardial infarction.
- miR-21 is a crucial mediator of serum EV-driven cardioprotection in AMI.
- Serum EVs represent a promising therapeutic strategy for managing AMI.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

